These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3719590)

  • 1. Destruction of both extensive local recurrent and primary breast cancer with topical aqueous 5-FU: a clinical observation.
    Zweig JI; Kabakow B
    Cancer Treat Rep; 1986 Jul; 70(7):936-7. PubMed ID: 3719590
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of terminal cancer and relapsed cancer by 5-5-FU(5-fluorouracil)].
    Uemura T; Amba T; Hamada M; Tanaka S
    Gan No Rinsho; 1968 Jul; 14(7):553-6. PubMed ID: 4177873
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant chemotherapy with chlorambucil and 5-fluorouracil in primary breast cancer (Cooperative Study Heidelberg).
    Kaufmann M; Fournier DV; Sievers H; Staib I; Wöllgens P; Nedden R; Lochbühler H; Queisser W; Christmann D; Bühner R; Pfuhl PJ; Henningsen B; Kuttig H; Wysocki S; Thüre D; Köhler C; Drings P
    Eur J Cancer (1965); 1980; Suppl 1():157-60. PubMed ID: 7032925
    [No Abstract]   [Full Text] [Related]  

  • 4. Acquisition of multidrug resistance in recurrent breast cancer demonstrated by the histoculture drug response assay.
    Tanino H; Oura S; Hoffman RM; Kubota T; Furukawa T; Arimoto J; Yoshimasu T; Hirai I; Bessho T; Suzuma T; Sakurai T; Naito Y
    Anticancer Res; 2001; 21(6A):4083-6. PubMed ID: 11911296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intra-arterial infusion chemotherapy for unresectable or recurrent breast cancer].
    An M; Matsumoto Y; Kishi T; Terakado H; Ikawa M; Hamada E; Watanabe Y; Nakasato S; Murata M; Takaki S; Miura T; Idezuki Y; Kobayashi M
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1330-2. PubMed ID: 9703820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer].
    Abe O; Izuo M; Enomoto K; Kubo K; Koyama H; Sakai K; Terasawa T; Tominaga T; Nomura Y
    Gan To Kagaku Ryoho; 1982 May; 9(5):866-73. PubMed ID: 7184431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
    Lee JM; Abeloff MD; Lenhard RE; Baker RR
    Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of adriamycin ointment in advanced or local recurrent breast cancer].
    Shimizu S; Katayama K; Matsukawa H; Gotoh H; Matsumoto A; Yokoyama H; Suda T; Gotoh H; Arita M; Jojima T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):590-2. PubMed ID: 3954381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Simultaneous radiochemotherapy in locoregional recurrent breast carcinoma after mastectomy. Results in patients with macroscopic residual tumor R2].
    Renner H; van Kampen M
    Strahlenther Onkol; 1994 Aug; 170(8):441-52. PubMed ID: 8085210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of ambulatory cancer chemotherapy for recurrent breast cancer].
    Takahashi N; Nitta A; Kunii Y; Ota K
    Gan To Kagaku Ryoho; 1994 Dec; 21 Suppl 4():439-43; discussion 443-4. PubMed ID: 7802447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent effect of adjuvant chemo-immunotherapy on recurrence rates in node-negative and node-positive breast cancer patients.
    Jungi WF; Senn HJ; Amgwerd R; Hochuli E
    Eur J Cancer (1965); 1980; Suppl 1():169-72. PubMed ID: 7032928
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclical combination chemotherapy in advanced breast cancer.
    Edelstyn GA; Marcrae KD
    Ann R Coll Surg Engl; 1974 Jun; 54(6):275-6. PubMed ID: 4833779
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of CAF'-endocrine therapy on advanced and recurrent breast cancer].
    Une Y; Sato Y; Kagaya H; Miyata S; Matsuoka S; Uchino J; Yakura Y
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2778-81. PubMed ID: 6548892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of topical 5-fluorouracil in the treatment of genital condylomas.
    Krebs HB
    Obstet Gynecol Clin North Am; 1987 Jun; 14(2):559-68. PubMed ID: 3323965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies in the management of potentially curable breast cancer.
    Wise L
    Surg Annu; 1974; 6():247-81. PubMed ID: 4215164
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) on advanced and recurrent breast cancer. Clinical study group of CMF for breast cancer in Japan].
    Nomura Y; Tominaga T; Adachi I; Koyama H; Fukami A
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1949-56. PubMed ID: 8085846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of advanced cancer of the breast with 5-fluorouracil.
    Vansant JH; Payne RL; Wheeler JR
    Am Surg; 1971 May; 37(5):287-9. PubMed ID: 5576598
    [No Abstract]   [Full Text] [Related]  

  • 18. [Late results of observing patients with extensive breast cancer who have undergone chemotherapy by infusion].
    Vikmanis UE; Sviatukhina OV; Lun'kova EF
    Vopr Onkol; 1974; 20(1):6-11. PubMed ID: 4216150
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclophosphamide. Evaluation in recurrent and progressive ovarian cancer.
    Decker DG; Malkasian GD; Mussey E; Johnson CE
    Am J Obstet Gynecol; 1967 Mar; 97(5):656-65. PubMed ID: 4959953
    [No Abstract]   [Full Text] [Related]  

  • 20. [Survival kinetics of breast cancer patients undergoing combined chemotherapy for recurrences and metastases].
    Korman DB; Maslova IA; Borisov AI
    Vopr Onkol; 1982; 28(8):14-9. PubMed ID: 7113064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.